- Citations, last 5 years
- 4
- Works, last 5 years
- 5
- h-index
- 9
- Scientists listed
- 1
- Grants since 2016
- 15
Grants received
2018–2021 · research · R44
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass
Natacha Le Moan · Omniox (United States) · funded by National Institutes of Health
2018–2021 · research · R44
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass
Jeffrey R Fineman · Omniox (United States) · funded by National Institutes of Health
2018–2022 · research · R44
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass
Jeffrey R Fineman · Omniox (United States) · funded by National Institutes of Health
2017–2026 · research · R44
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass
Jeffrey R Fineman · Omniox (United States) · funded by National Institutes of Health
2017–2026 · research · R44
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass
Jeffrey R Fineman · Omniox (United States) · funded by National Institutes of Health
2017–2022 · research · R01
Development of PET imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel H-NOX oxygen carrier
Simon R Cherry · Omniox (United States) · funded by National Institutes of Health
2017–2023 · research · R01
Development of PET imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel H-NOX oxygen carrier
Simon R Cherry · Omniox (United States) · funded by National Institutes of Health
2017–2022 · research · R01
Development of PET imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel H-NOX oxygen carrier
Simon R Cherry · Omniox (United States) · funded by National Institutes of Health
2017–2018 · research · R44
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass
Jeffrey R Fineman · Omniox (United States) · funded by National Institutes of Health
2017–2023 · research · R01
Development of PET imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel H-NOX oxygen carrier
Jonathan A Winger · Omniox (United States) · funded by National Institutes of Health
2017–2023 · research · R01
Development of PET imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel H-NOX oxygen carrier
Jonathan A Winger · Omniox (United States) · funded by National Institutes of Health
2017–2022 · research · R01
Development of PET imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel H-NOX oxygen carrier
Simon R Cherry · Omniox (United States) · funded by National Institutes of Health
2017–2027 · research · R44
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass
Jeffrey R Fineman · Omniox (United States) · funded by National Institutes of Health
2016–2020 · research · R44
Reducing Brain Injury After Focal Ischemia Using a Nitric Oxide-Neutral Oxygen Carrier
Ana Krtolica · Omniox (United States) · funded by National Institutes of Health
2016–2018 · research · R44
Reducing Brain Injury After Focal Ischemia Using a Nitric Oxide-Neutral Oxygen Carrier
Stephen Cary · Omniox (United States) · funded by National Institutes of Health
